Arcutis Biotherapeutics, Inc.
ARQT
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 376.1 | 376.1 | 196.5 | 59.6 | 3.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 36.7 | 36.7 | 19.1 | 5.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 339.4 | 339.4 | 177.4 | 54.6 | 2.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 129.5 | 99.2 | 81.5 | 65.8 | 71.4 | 44.8 | 30.9 | 49.6 | 13.5 | 38.1 | |
| Cost of Revenues | 11.7 | 8.7 | 7.5 | 8.8 | 6.9 | 5.5 | 3.5 | 3.3 | 2.4 | 1.2 | |
| Gross Profit | 117.8 | 90.5 | 74.0 | 57.0 | 64.5 | 39.3 | 27.4 | 46.3 | 11.1 | 36.9 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 110.6 | 182.4 | 145.6 | 115.3 | 36.5 | 17.9 | 3.4 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 185.1 | 122.1 | 61.0 | 21.3 | 6.6 | 1.8 | 0.7 | |
| Depreciation & Amortization | 5.5 | 5.4 | 2.6 | 1.9 | 5.8 | 0.5 | 0.1 | 0.2 | 0.5 | 0.0 | |
| Total Operating Expenses | 351.6 | 351.6 | 305.8 | 295.7 | 304.6 | 206.5 | 136.6 | 43.1 | 19.7 | 4.1 | |
| Operating Income | -12.2 | -12.2 | -128.4 | -241.1 | -301.6 | -206.5 | -136.6 | -43.1 | -19.7 | -4.1 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23.8 | 26.2 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 48.5 | 47.6 | ||
| Depreciation & Amortization | 1.3 | 0.6 | 0.6 | 3.1 | 0.5 | 1.4 | 0.4 | 0.4 | 0.4 | 0.4 | ||
| Total Operating Expenses | 99.4 | 82.0 | 88.6 | 81.5 | 72.1 | 78.3 | 77.5 | 77.9 | 72.3 | 73.8 | ||
| Operating Income | 18.4 | 8.5 | -14.6 | -24.5 | -7.6 | -39.1 | -50.1 | -31.6 | -61.2 | -36.9 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 12.1 | 12.1 | 27.2 | 29.7 | 15.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -2.7 | -2.7 | -11.0 | -17.9 | -9.8 | 0.2 | 1.0 | 1.1 | 0.5 | -0.9 | |
| IBT | -15.0 | -15.0 | -139.4 | -259.0 | -311.5 | -206.4 | -135.7 | -42.0 | -19.3 | -5.0 | |
| Income Tax Expense | 1.2 | 1.2 | 0.6 | 3.1 | 9.8 | -0.5 | 0.0 | 0.0 | -0.5 | 0.0 | |
| Net Income | -16.1 | -16.1 | -140.0 | -262.1 | -321.3 | -205.9 | -135.7 | -42.0 | -19.3 | -5.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.8 | ||
| Interest Expense | 3.0 | 3.1 | 3.0 | 3.0 | 5.6 | 6.7 | 7.5 | 7.5 | 7.8 | 7.6 | ||
| Other Expense | -0.5 | -1.0 | -0.9 | -0.3 | -2.8 | -2.5 | -2.3 | -3.4 | -5.1 | -4.8 | ||
| IBT | 17.9 | 7.5 | -15.5 | -24.8 | -10.5 | -41.5 | -52.3 | -35.1 | -66.3 | -41.7 | ||
| Income Tax Expense | 0.5 | 0.1 | 0.3 | 0.3 | 0.3 | 0.0 | 0.0 | 0.3 | 0.0 | 3.0 | ||
| Net Income | 17.4 | 7.4 | -15.9 | -25.1 | -10.8 | -41.5 | -52.3 | -35.4 | -66.3 | -44.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-3.78 | $-5.84 | $-4.17 | $-3.80 | $-1.20 | $-1.07 | $-0.28 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-3.78 | $-5.84 | $-4.17 | $-3.80 | $-1.20 | $-1.07 | $-0.28 | |
| Shares Outstanding | 128.3 | 127.2 | 121.0 | 69.3 | 55.0 | 49.4 | 35.7 | 35.1 | 18.0 | 18.0 | |
| Diluted Shares Outstanding | 135.6 | 127.2 | 121.0 | 69.3 | 55.0 | 49.4 | 35.7 | 35.1 | 18.0 | 18.0 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.72 | $-0.73 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.72 | $-0.73 | ||
| Shares Outstanding | 128.3 | 127.6 | 127.0 | 126.0 | 121.0 | 124.3 | 123.5 | 111.0 | 92.6 | 61.7 | ||
| Diluted Shares Outstanding | 135.6 | 132.9 | 127.0 | 126.0 | 121.0 | 124.3 | 123.5 | 111.0 | 92.6 | 61.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 84.9 | 71.3 | 88.4 | 53.6 | 96.4 | 65.1 | 63.3 | 39.4 | 3.4 | |
| Short Term Investments | 278.2 | 156.6 | 183.5 | 355.9 | 290.6 | 219.4 | 37.9 | 11.5 | 0.0 | |
| Total Cash & ST Investments | 363.1 | 228.0 | 271.9 | 409.6 | 387.1 | 284.4 | 101.3 | 50.9 | 3.4 | |
| Accounts Receivable | 43.4 | 73.1 | 25.8 | 8.5 | 0.4 | 0.5 | 0.0 | 0.0 | 0.0 | |
| Inventory | 13.9 | 14.5 | 13.1 | 7.5 | 1.2 | -0.5 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 14.2 | 20.3 | 19.6 | 10.6 | 14.2 | 8.4 | 5.2 | 0.2 | 0.4 | |
| Total Current Assets | 434.6 | 335.8 | 330.4 | 437.4 | 402.8 | 292.8 | 106.5 | 51.1 | 3.8 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 47.1 | 73.0 | 53.1 | 71.3 | 134.9 | 84.9 | 190.7 | 89.3 | 107.5 | 105.1 | |
| Short Term Investments | 143.9 | 118.1 | 145.0 | 156.6 | 195.7 | 278.2 | 213.8 | 183.5 | 119.6 | 163.6 | |
| Total Cash & ST Investments | 191.1 | 191.1 | 198.1 | 228.0 | 330.6 | 363.1 | 404.5 | 272.8 | 227.1 | 268.7 | |
| Accounts Receivable | 115.1 | 106.7 | 85.4 | 73.1 | 60.1 | 43.4 | 37.2 | 25.8 | 19.4 | 17.2 | |
| Inventory | 22.4 | 16.3 | 16.6 | 14.5 | 14.0 | 13.9 | 13.2 | 13.1 | 13.9 | 10.5 | |
| Other Current Assets | 20.6 | 18.6 | 23.6 | 20.3 | 19.0 | 14.9 | 13.8 | 19.6 | 21.1 | 12.5 | |
| Total Current Assets | 349.2 | 332.8 | 323.7 | 335.8 | 423.7 | 434.6 | 468.1 | 330.4 | 281.5 | 308.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.5 | 3.0 | 3.9 | 4.6 | 5.3 | 5.4 | 0.5 | 0.0 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 6.1 | 9.5 | 6.4 | 7.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.6 | 0.6 | 0.6 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 10.2 | 13.1 | 10.9 | 11.9 | 5.4 | 5.4 | 0.5 | 0.0 | 0.0 | |
| Total Assets | 444.8 | 348.9 | 341.4 | 449.3 | 408.2 | 298.3 | 107.0 | 51.1 | 3.8 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 5.8 | 3.1 | 3.3 | 3.0 | 3.2 | 3.5 | 3.6 | 3.9 | 4.2 | 4.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 15.4 | 15.9 | 16.5 | 9.5 | 9.8 | 6.1 | 6.3 | 6.4 | 6.6 | 6.8 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | |
| Total Long-Term Assets | 21.8 | 19.7 | 20.4 | 13.1 | 13.6 | 10.2 | 10.5 | 10.9 | 11.4 | 11.8 | |
| Total Assets | 371.0 | 352.4 | 344.1 | 348.9 | 437.4 | 444.8 | 478.5 | 341.4 | 293.0 | 320.7 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.9 | 14.2 | 12.0 | 8.8 | 7.4 | 7.1 | 1.4 | 1.8 | 0.5 | |
| Short-Term Debt | 0.8 | 0.8 | 1.5 | 0.7 | 0.4 | 0.0 | 0.2 | 0.0 | 0.0 | |
| Other Current Liabilities | 42.6 | 66.0 | 33.2 | 28.3 | 25.5 | 15.5 | 3.7 | 0.9 | 0.2 | |
| Current Liabilities | 51.4 | 81.0 | 46.7 | 37.8 | 33.3 | 22.6 | 5.2 | 2.7 | 0.7 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.8 | 15.1 | 24.5 | 14.2 | 19.3 | 7.9 | 13.0 | 12.0 | 13.2 | 17.2 | |
| Short-Term Debt | 1.0 | 1.0 | 0.8 | 0.8 | 100.3 | 1.6 | 0.8 | 1.5 | 1.4 | 1.4 | |
| Other Current Liabilities | 93.0 | 87.9 | 65.8 | 66.0 | 52.8 | 41.9 | 33.6 | 33.2 | 27.3 | 18.1 | |
| Current Liabilities | 99.8 | 103.9 | 91.1 | 81.0 | 172.4 | 51.4 | 47.3 | 46.7 | 41.9 | 36.7 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 203.8 | 109.8 | 205.2 | 201.9 | 77.1 | 5.0 | 0.1 | 0.0 | 0.0 | |
| Capital Leases | 3.0 | 3.4 | 4.1 | 4.8 | 5.2 | 5.0 | 0.3 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 258.3 | 191.3 | 252.7 | 239.7 | 110.5 | 27.6 | 172.0 | 75.1 | 8.8 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 5.3 | 109.2 | 110.0 | 109.8 | 107.9 | 206.8 | 206.0 | 205.2 | 204.4 | 203.5 | |
| Capital Leases | 5.3 | 2.1 | 3.2 | 3.4 | 3.6 | 3.0 | 3.2 | 3.4 | 4.3 | 4.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 212.9 | 213.5 | 201.4 | 191.3 | 280.7 | 258.3 | 253.6 | 252.7 | 246.2 | 240.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,069.6 | -1,121.9 | -981.9 | -719.8 | -408.3 | -202.0 | -66.3 | -24.3 | -5.0 | |
| Comprehensive Income | -0.3 | 0.0 | 0.0 | -1.1 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 186.4 | 157.5 | 88.7 | 209.6 | 297.7 | 270.6 | -65.0 | -24.0 | -5.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,155.5 | -1,162.9 | -1,147.0 | -1,121.9 | -1,111.2 | -1,069.6 | -1,017.3 | -981.9 | -915.6 | -870.9 | |
| Comprehensive Income | -0.1 | 0.0 | -0.1 | 0.0 | 0.5 | -0.3 | -0.1 | 0.0 | -0.2 | -0.3 | |
| Total Common Equity | 158.1 | 139.0 | 142.7 | 157.5 | 156.6 | 186.4 | 224.9 | 88.7 | 46.7 | 80.5 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 207.6 | 110.6 | 205.9 | 202.5 | 77.6 | 5.0 | 0.3 | 0.0 | 0.0 | |
| Book Value | 186.4 | 157.5 | 88.7 | 209.6 | 297.7 | 270.6 | -65.0 | -24.0 | -5.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 158.1 | 139.0 | 142.7 | 157.5 | 156.6 | 186.4 | 224.9 | 88.7 | 46.7 | 80.5 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -198.8 | -16.1 | -140.0 | -262.1 | -311.5 | -206.4 | -135.7 | -42.0 | -19.3 | -5.0 | |
| Depreciation & Amortization | 1.5 | 4.7 | 2.6 | 1.5 | 0.9 | 0.5 | 0.1 | 0.2 | 0.0 | 0.0 | |
| Stock-Based Compensation | 41.3 | 40.4 | 41.7 | 38.8 | 32.7 | 23.9 | 7.9 | 0.8 | 0.2 | 0.0 | |
| Change Working Capital | -18.5 | -34.8 | -15.1 | -23.5 | -10.2 | 3.6 | 14.1 | -1.5 | 2.1 | 0.3 | |
| Change In Accounts Receivable | -25.1 | -73.2 | -47.3 | -17.3 | -8.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -9.3 | -1.7 | 2.2 | 3.2 | 1.6 | 0.2 | 5.7 | -0.5 | 1.3 | 0.5 | |
| Change In Inventories | -3.4 | -7.3 | -0.4 | -5.6 | -7.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 60.8 | 0.3 | -1.4 | -1.8 | 30.3 | 0.3 | 0.3 | -0.4 | 2.9 | 0.9 | |
| Cash from Operations | -177.0 | 0.0 | 0.0 | -247.1 | -257.7 | -174.6 | -113.0 | -42.8 | -14.1 | -3.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 17.4 | 7.4 | -15.9 | -25.1 | -10.8 | -41.5 | -52.3 | -35.4 | -66.3 | -44.8 | |
| Depreciation & Amortization | 0.6 | 0.6 | 0.4 | 3.1 | 0.5 | 1.8 | 0.0 | 0.4 | 0.4 | 0.4 | |
| Stock-Based Compensation | 10.1 | 10.0 | 10.5 | 9.8 | 9.4 | 9.8 | 12.5 | 10.0 | 8.8 | 10.0 | |
| Change Working Capital | -2.3 | -19.9 | 5.1 | -17.7 | -1.6 | -3.8 | -4.3 | -5.4 | 0.4 | -9.2 | |
| Change In Accounts Receivable | -31.1 | -8.4 | -21.3 | -12.3 | -14.1 | -16.6 | -5.2 | -11.3 | -6.4 | -2.2 | |
| Change In Accounts Payable | 6.7 | -9.3 | 0.6 | 0.3 | -0.1 | 6.5 | -5.2 | 1.0 | -1.2 | -4.0 | |
| Change In Inventories | 0.0 | -5.9 | 0.5 | -2.0 | -0.3 | 0.6 | -0.6 | -0.1 | 0.8 | -3.4 | |
| Other Non-cash Items | 0.5 | 0.2 | 0.2 | -0.5 | 1.8 | -0.9 | -1.1 | -1.2 | 16.8 | 1.1 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -56.2 | -44.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.7 | -0.1 | -0.4 | -23.3 | -1.0 | -0.3 | -0.3 | 0.0 | 0.0 | |
| Acquisitions | 16.6 | 0.0 | 0.0 | 0.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -372.3 | -247.0 | -254.8 | -225.8 | -415.4 | -292.5 | -279.1 | -60.8 | -11.5 | 0.0 | |
| Sales of Investment | 264.9 | 227.4 | 288.8 | 406.5 | 351.5 | 217.6 | 97.6 | 34.8 | 0.0 | 0.0 | |
| Other Investing Activities | -45.3 | 0.0 | 0.0 | 0.0 | -23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -107.5 | 0.0 | 0.0 | 180.2 | -87.2 | -76.0 | -181.8 | -26.3 | -11.5 | 0.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | 0.0 | -0.1 | -0.6 | -5.0 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 62.2 | -45.6 | |
| Investments | -89.2 | -68.5 | -33.2 | -56.1 | -17.4 | -5.7 | -125.8 | -106.0 | -118.2 | -22.4 | |
| Sales of Investment | 55.0 | 43.3 | 60.7 | 68.5 | 57.3 | 90.6 | 63.6 | 77.3 | 56.0 | 68.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -62.2 | 45.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -62.2 | 45.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 3.3 | 110.6 | -95.3 | 3.4 | 125.0 | 72.6 | 4.7 | 0.3 | 0.0 | 0.0 | |
| Issuance of Common Stock | 263.4 | 0.0 | 0.0 | 98.9 | 176.0 | 207.5 | 297.0 | 94.2 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 12.5 | 0.8 | 0.6 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 100.2 | 0.0 | 0.0 | 2.4 | 113.3 | 73.6 | 0.5 | -1.1 | 61.6 | 7.1 | |
| Cash from Financing | 263.4 | 0.0 | 0.0 | 101.3 | 301.8 | 281.9 | 298.1 | 93.1 | 61.6 | 7.1 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 6.3 | -103.9 | -0.6 | 0.2 | -97.6 | 0.6 | 0.8 | 0.8 | 0.8 | 0.9 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 98.9 | 0.9 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.9 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 99.3 | 0.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -21.2 | -28.7 | -17.4 | 34.4 | -43.1 | 31.4 | 3.3 | 23.9 | 36.0 | 3.3 | |
| Closing Cash Balance | 84.9 | 43.2 | 72.0 | 89.3 | 54.9 | 98.0 | 66.6 | 63.3 | 39.4 | 3.4 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -4.2 | -25.6 | 19.3 | -18.2 | -63.5 | 50.6 | -105.8 | 101.4 | -19.1 | 2.4 | |
| Closing Cash Balance | 43.2 | 47.4 | 73.0 | 53.7 | 72.0 | 135.5 | 84.9 | 190.7 | 89.3 | 108.4 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -177.0 | -6.3 | -112.3 | -247.5 | -281.0 | -175.6 | -113.4 | -43.1 | -14.1 | -3.8 | |
| Real Free Cash Flow | -218.3 | -46.7 | -154.0 | -286.3 | -313.7 | -199.5 | -121.3 | -44.0 | -14.2 | -3.8 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 26.2 | -1.8 | 0.2 | -31.0 | -5.7 | -34.8 | -45.1 | -31.6 | -56.3 | -44.0 | |
| Real Free Cash Flow | 16.1 | -11.8 | -10.2 | -40.8 | -15.1 | -44.6 | -57.6 | -41.6 | -65.0 | -54.0 |
